RT Journal Article SR Electronic T1 Intuitive movement-based prosthesis control enables arm amputees to reach naturally in virtual reality JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2022.10.15.22281053 DO 10.1101/2022.10.15.22281053 A1 Segas, Effie A1 Mick, Sébastien A1 Leconte, Vincent A1 Dubois, Océane A1 Klotz, Rémi A1 Cattaert, Daniel A1 de Rugy, Aymar YR 2023 UL http://medrxiv.org/content/early/2023/08/10/2022.10.15.22281053.abstract AB Impressive progress is being made in bionic limbs design and control. Yet, controlling the numerous joints of a prosthetic arm necessary to place the hand at a correct position and orientation to grasp objects remains challenging. Here, we designed an intuitive, movement-based prosthesis control that leverages natural arm coordination to predict distal joints missing to people with transhumeral limb loss based on proximal residual limb motion and knowledge of the movement goal. This control was validated on 29 participants, including 7 with above-elbow limb loss, who picked and placed bottles in a wide range of locations in virtual reality, with median success rates over 99% and movement times identical to those of natural movements. This control also enabled 15 participants, including 3 with limb difference, to reach and grasp real objects with a robotic arm operated according to the same principle. Remarkably, this was achieved without any prior training, indicating that this control is intuitive and instantaneously usable. It could be used for phantom limb pain management in virtual reality, or to augment reaching capabilities of invasive neural interfaces usually more focused on hand and grasp control.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the CNRS interdisciplinary project RoBioVis, and the ANR-DGA-ASTRID grant CoBioPro (ANR-20-ASTR-0012-1).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee CPP Est II of CHU Besancon gave ethical approval for this work (CCP Est II: 2019-A02890-57).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data recorded during the three experiments are available at https://doi.org/10.5281/zenodo.7187850 https://doi.org/10.5281/zenodo.7187850